Brief: Gentian Q1 EBITDA Turns To Profit Of NOK 4.8 Mln
April 30 (Reuters) - Gentian Diagnostics ASA GENT.OL :
* RECORD SALES OF NOK 38.5 MILLION IN 1Q24, UP 22% VERSUS
1Q23
(19% ORGANIC GROWTH)
* EBITDA OF NOK 4.8 MILLION IN 1Q24 VERSUS NOK -0.5 MILLION
IN
1Q23
Source text for Eikon: ID:nObinRxcTa
Further company coverage: GENT.OL
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Gentian Diagnostics ASA
See all newsBrief: Gentian Diagnostics Q3 Sales At NOK 51.1 Million
Brief: Gentian Diagnostics Q2 EBITDA At NOK 8.1 Mln
Brief: Gentian Diagnostics Q2 EBITDA Up At NOK 8.1 Million
Brief: Essange Reagents And Gentian Diagnostics Announce Collaboration Agreement
Brief: Gentian Diagnostics: Vatne Capital Reduces Indirect Ownership